GSK commits to further support of BioVerys’ TB drug May 7, 2024 AutoBot News 0 GSK has expanded a collaboration with BioVersys on a new drug candidate for tuberculosis (TB) and contributed to an extension to the Swiss biotech’s third-round financing.